Fund shareholders of AVALO THERAPEUTICS INC
ISIN US05338F3064 · United States · LEI 549300GPK6FPJ3X8SZ39
- Fund shareholders
- 41
- Of which ETFs
- 5 36 other funds
- Value held
- 67M $
- Share of capital
- 8.7 % of 53.6M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Stock Selector Small Cap Fund Fidelity Capital Trust | 785,400 | 10.5M $ | 0.15 % | 1.46 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 678,823 | 10.1M $ | 0.13 % | 1.27 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Small Cap Opportunities Fund Fidelity Securities Fund | 556,500 | 7.5M $ | 0.15 % | 1.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 537,792 | 8M $ | 0.00 % | 1.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 358,300 | 4.8M $ | 0.25 % | 0.67 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 348,393 | 5.2M $ | 0.12 % | 0.65 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 314,490 | 4.7M $ | 0.05 % | 0.59 % | as of Mar 31, 2026 ↗ |
| SmallCap Fund Principal Funds, Inc | 224,700 | 3M $ | 0.14 % | 0.42 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Small Cap Core Fund Fidelity Concord Street Trust | 212,400 | 2.8M $ | 0.18 % | 0.40 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 163,278 | 2.4M $ | 0.00 % | 0.30 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 111,577 | 1.5M $ | 0.14 % | 0.21 % | as of Apr 30, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 103,922 | 1.8M $ | 0.00 % | 0.19 % | as of Feb 28, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 74,655 | 1.3M $ | 0.00 % | 0.14 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 39,723 | 593.1K $ | 0.05 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 24,839 | 434.7K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 19,975 | 349.6K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 12,867 | 225.2K $ | 0.00 % | 0.02 % | as of Feb 28, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 11,668 | 174.2K $ | 0.44 % | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 10,852 | 162K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 10,800 | 144.7K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Harbor Health Care ETF Harbor ETF Trust | 10,218 | 136.9K $ | 0.50 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 10,000 | 134K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| NORTH SQUARE KENNEDY MICROCAP FUND Exchange Place Advisors Trust | 9,832 | 172.1K $ | 0.58 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 9,276 | 124.3K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 7,772 | 116K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 6,914 | 103.2K $ | 0.51 % | 0.01 % | as of Mar 31, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 6,829 | 91.5K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 6,000 | 89.6K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| GMO U.S. Small Cap Value Fund GMO TRUST | 3,002 | 52.5K $ | 0.12 % | 0.01 % | as of Feb 28, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 2,806 | 41.9K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| U.S. Social Core Equity 2 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 2,654 | 35.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 1,818 | 24.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Moderate Allocation Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 980 | 14.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Spectrum Moderate Growth Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 954 | 16.7K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 746 | 11.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Spectrum Moderate Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 353 | 6.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 316 | 4.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Spectrum Conservative Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 231 | 4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 140 | 1.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 137 | 1.8K $ | 0.00 % | as of Apr 30, 2026 ↗ | |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 96 | 1.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| NORTH SQUARE KENNEDY MICROCAP FUND Exchange Place Advisors Trust | 0.58 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 0.51 % | as of Mar 31, 2026 ↗ |
| Harbor Health Care ETF Harbor ETF Trust | 0.50 % | as of Apr 30, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 0.44 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 0.25 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Small Cap Core Fund Fidelity Concord Street Trust | 0.18 % | as of Apr 30, 2026 ↗ |
| Fidelity Stock Selector Small Cap Fund Fidelity Capital Trust | 0.15 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Small Cap Opportunities Fund Fidelity Securities Fund | 0.15 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.14 % | as of Apr 30, 2026 ↗ |
| SmallCap Fund Principal Funds, Inc | 0.14 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 41 | +18 | 4,682,028 | +336.7 % |
| 2026Q1 | 23 | +6 | 1,072,062 | +10.4 % |
| 2025Q4 | 17 | +10 | 970,781 | +247.3 % |
| 2025Q3 | 7 | +2 | 279,520 | +8.3 % |
| 2025Q2 | 5 | 0 | 258,129 | +48.0 % |
| 2025Q1 | 5 | 0 | 174,411 | +786.6 % |
| 2024Q4 | 5 | -2 | 19,672 | -2.4 % |
| 2024Q3 | 7 | 0 | 20,160 | +139.2 % |
| 2024Q2 | 7 | +3 | 8,429 | -46.6 % |
| 2024Q1 | 4 | 15,776 |
Institutional managers
93 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 2,879,481 | 43M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 2,162,684 | 32.3K $ | as of Mar 31, 2026 |
| Caligan Partners LP | 1,635,023 | 24.4M $ | as of Mar 31, 2026 |
| BVF INC/IL | 1,632,845 | 24.4M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 1,410,000 | 21.1M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 1,340,840 | 20M $ | as of Mar 31, 2026 |
| Nantahala Capital Management, LLC | 1,235,000 | 18.4M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,141,980 | 17M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 916,142 | 13.7M $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 916,000 | 13.7M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 856,962 | 12.8M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 854,000 | 12.8M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 835,484 | 12.5M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 738,383 | 11M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 731,586 | 10.9M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 662,968 | 9.9M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 643,000 | 9.6M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 483,000 | 7.2M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 475,165 | 7.1M $ | as of Mar 31, 2026 |
| JENNISON ASSOCIATES LLC | 470,775 | 7M $ | as of Mar 31, 2026 |
| Caption Management, LLC | 455,000 | 6.8M $ | as of Mar 31, 2026 |
| Soleus Capital Management, L.P. | 441,978 | 6.6M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 422,781 | 6.3M $ | as of Mar 31, 2026 |
| KENNEDY CAPITAL MANAGEMENT LLC | 387,982 | 5.8M $ | as of Mar 31, 2026 |
| DV Trading LLC | 360,064 | 5.4M $ | as of Mar 31, 2026 |
Declared shareholders of AVALO THERAPEUTICS INC
There are 13 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P and 9 others | 9.99 % | 2,347,845 | as of Mar 31, 2026 · SCHEDULE 13G |
| Commodore Capital LP and 3 others | 9.90 % | 5,721,109 | as of Jun 11, 2026 · SCHEDULE 13G |
| RA Capital Management, L.P. and 3 others | 9.90 % | 2,455,655 | as of Mar 31, 2026 · SCHEDULE 13G |
| T. Rowe Price Investment Management, Inc. | 9.50 % | 2,162,684 | as of Mar 31, 2026 · SCHEDULE 13G |
| TCG Crossover GP II, LLC and 2 others | 7.90 % | 3,017,120 | as of May 5, 2026 · SCHEDULE 13G |
| Caligan Partners LP and 1 other | 7.20 % | 1,635,023 | as of Mar 31, 2026 · SCHEDULE 13G |
| FMR LLC and 1 other | 6.10 % | 3,188,401 | as of May 29, 2026 · SCHEDULE 13G |
| Deep Track Capital, LP and 2 others | 5.81 % | 3,055,027 | as of May 22, 2026 · SCHEDULE 13G |
| Avoro Capital Advisors LLC and 1 other | 5.75 % | 1,410,000 | as of Mar 31, 2026 · SCHEDULE 13G |
| Affinity Asset Advisors, LLC and 1 other | 5.50 % | 1,340,840 | as of Mar 31, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 2 others | 5.20 % | 2,710,817 | as of May 22, 2026 · SCHEDULE 13G |
| Logos Global Management LP and 4 others | 3.20 % | 1,675,000 | as of Mar 31, 2026 · SCHEDULE 13G |
| OrbiMed Advisors LLC | 2.10 % | 475,165 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of AVALO THERAPEUTICS INC". https://titelia.com/en/stocks/avalo-therapeutics-inc-US05338F3064